Member Info for Dibs61

So now most of the questions are answered. We know where we stand here and what the plan is. And its a mightily exciting one. From being in a position where we thought much of the future profits would be given away in an early takeover or licensing deal we can see SNG retaining 100% ownership of this mega drug. With plenty of cash in the bank, an exciting P3 trial awaits and by early next year we should have both the initial results and certainly the home trial results too.

I believe by then Big Pharma will be falling over themselves to get their hands on SNG001. And if they don't, well fine, we'll make billions out of it. Either way surely a win-win here?

Nice weekend everyone

GLA and DYOR

OK highly doubtful but who knows? Who would've forecast the gigantic SP increase at Greatland Gold. I had a shareholding there way back when it was under a penny and sold out! In fact I well remember buying after an investor evening where I saw Gervais thingy speaking. It all sounded too good to be true.... but it wasn't! So I missed out completely.

Hopefully I won't make that same mistake here. Not saying its going to do another GGP but it certainly has potential to multi bag from here with a sub £6m MC. Just a sniff of Ozzie gold here will have the herd sweeping in. And possibly a natural home for some of those GGP profits?

Anyway I've taken a position here today and looking forward to the ride. Should be interesting. Nice strong finish to the day as well after a bit of interim results sell on news. Guess the next news is the decision whether to opt into the Pilbara acreage - in the same region as GGP's discovery...... Then they should be looking to work out an exploration plan. I can't resist a micro gold explorer!

My 25k buy yesterday still hasn’t been printed.

Placing overhang cleared?

This looks oversold now. The mine isn’t even anywhere near the conflict zone so, as usual, Mr Market has overdone it.

Add to that the main players Turkey and Russia don’t want a spat, especially when trying to handle a global pandemic.

So I reckon heads will be banged together and this will be sorted out and the SP can resume an upwards climb.

I notice it’s stated that it’s a randomised placebo based trial. However the P2 Trial was also double-blinded. Does anyone know or can they confirm that the P3 trial is single blinded not double blinded? Can we assume that or have I missed something?

Looks a very attractive proposition. Picked up 25k shares initially. Mom’s haven’t printed the trade though...;)

A monumental RNS tonight from the company. What a statement to both UK Pharma, UK regulatory authorities and, most of all, the UK government. Aren’t our government absolutely b useless! OK you don5 want to help us we’ll go elsewhere. Given them the finger basically. Good. The whole emphasis has clearly moved over to the USA. Look at the evidence:

1. The trial to be run through the FDA.
2. Paraxel Biotech (a US based company) to conduct the P3 trial
3. Akron Biotech (a US based company) to manufacture the SNG001 drug
4. Aerogen (good presence in US though international) to manufacture inhalation devices
5. Last but not least the US investors currently on the Share register. I expect further US investors to climb onboard in the placing. Those TR1’s are going to be very interesting.

Yes, for now, they are going it alone but cash-rich and 100% in control of their destiny. I previously thought AZN were the favourites to take them out but now I think the chances it will be a US suitor have grown substantially. Pfizer, Gilead, Lily....? Any one of those.

"Five years from now £50 might be a reasonable target. But in the next 12 months it's £5 to £10."

HSD - wow thats some achievement to make such an incredibly bullish forecast sound soooo bearish lmao

MM's happily scooping up all these trading shares @ 2.22+ Price not budging and you can bet we are not seeing all the buying going on

Some really great posts on here today. This board is truly top notch when it comes to research. Sadly one or two poor ones too -HSD surely you’ve been around here long enough to know better than your recent post dear me.... *shakes head*

This treatment is proven to show efficacy on most viral infections including future pandemic viruses. It is quite generic in that regard.

It has also been shown to have efficacy on COPD exacerbations.

If that lot isn’t worth multi billions in a future market I don’t know what is!

I meant ‘poisoning’ people!

Antonios - tell you what, you try it first, test it thoroughly. Then we’ll see.

PS.Don’t forget positioning people is a speciality there ;)

Rasher77 = Org30

Either that or is the love child of.

Cue denial : I don’t even know who you’re talking about?! Who is this ‘Org30’ lol

17,234 new Covid cases today
143 more deaths

How many more before this inept UK government does something positive and gets off its ass to treat these people before more unnecessary suffering occurs? SNG001.

670p would make everybody a good return. However it is way too cheap. £1bn for a drug which can effectively and cheaply treat COVID-19, other viruses too and COPD exacerbation - en masse - globally. Errr no don’t think so. Come back again with a sensible offer, which is multiples of that number. RM knows this only too well.

To be out of this imo.

I’ll be surprised if we don’t test the previous all time closing high of 249 today.

Firstly I want to address your placing question. This is not news. It’s well known to many investors, certainly most here, and indeed the wider market that SNG will require further funding. Because RM has openly stated. Now the question is how they will get that funding. It could be provided by the UK government. It could be via large institutional interest that has already been shown. Or it could be via a partnership deal/JV. It certainly WONT be a typical AIM bucket shop job.

Secondly, a pivotal trial. It’s very likely that emergency use authorisation will be given prior to the completion of any further clinical trials required. So, no, we should not miss out on a winter roll out but the scale of the roll out is as yet unknown. 2021 will see a major scale up. Only 3 months to wait!

Let’s just round it up to £10

There has been a very substantial increase in positive Covid cases since August/September. Which must’ve made recruiting easier? Surely they must be close to, or finished, recruiting for the Home Trial by now? An RNS to confirm would be received well by the market as we would then be able to gauge initial results outcome. I’d estimate by end November.

The potential for home use is our ultimate USP. AFAIAA no other treatment can be used in this way either for pre-hospital or prophylactic.